You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Search all journals

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

Copyright © 2026 by Sage Publications.京ICP备09090397号-11

Search results

Search results page

Articles (65)

Journals (0)

1-10 of 65 results for HR /HER2– metastatic breast cancer

Sort by:

Relevance

Select all

Select all

Sort by:

Relevance

Select article: Ribociclib in HR+/HER2− Advanced or Metastatic Breast Cancer Patients

Retricted access

Review article

First published 2019-5

Ribociclib in HR+/HER2− Advanced or Metastatic Breast Cancer Patients

Kaitlin Rascon, Goran Flajc, Carmine De Angelis [...]

Annals of Pharmacotherapy

Select article: Clinical Outcomes with First-line Endocrine Therapy or Chemotherapy in Postmenopausal HR+/HER2-Metastatic Breast Cancer

Open access

Research article

First published 2015

Clinical Outcomes with First-line Endocrine Therapy or Chemotherapy in Postmenopausal HR+/HER2-Metastatic Breast Cancer

Yan Song, Yanni Hao, Alexander R. Macalalad [...]

Breast Cancer: Basic and Clinical Research

Select article: Evolving perspectives on the treatment of HR+/HER2+ metastatic breast cancer

Open access

Review article

First published 2023

Evolving perspectives on the treatment of HR+/HER2+ metastatic breast cancer

Mark Pegram, Richard Pietras, Chau T. Dang [...]

Therapeutic Advances in Medical Oncology

Select article: Real-world analysis of HER2-ultralow in HR+/HER2– metastatic breast cancer: prevalence and first-line chemotherapy outcomes

Open access

Research article

First published 2025

Real-world analysis of HER2-ultralow in HR+/HER2– metastatic breast cancer: prevalence and first-line chemotherapy outcomes

Laurent Mathiot, Olivier Kerdraon, Florent Le Borgne [...]

Therapeutic Advances in Medical Oncology

Select article: A multicenter analysis of treatment patterns and clinical outcomes of subsequent therapies after progression on palbociclib in HR+/HER2− metastatic breast cancer

Open access

Research article

First published 2021

A multicenter analysis of treatment patterns and clinical outcomes of subsequent therapies after progression on palbociclib in HR+/HER2− metastatic breast cancer

Yi Li, Wei Li, Chengcheng Gong [...]

Therapeutic Advances in Medical Oncology

Select article: Early Application of Palbociclib Plus Endocrine Therapy in HR+/HER2− Metastatic Breast Cancer: A Better Choice Based on Data From the Chinese Population

Open access

Research article

First published 2022

Early Application of Palbociclib Plus Endocrine Therapy in HR+/HER2− Metastatic Breast Cancer: A Better Choice Based on Data From the Chinese Population

Yusi Zhang, Wenlin Chen, Shuanglong Chen [...]

Technology in Cancer Research & Treatment

Select article: Real-world comparison of palbociclib,abemaciclib,and dalpiciclib as first-line treatments for Chinese HR+/HER2−metastatic breast cancer patients: a multicenter study (YOUNGBC-28)

Open access

Research article

First published 2024

Real-world comparison of palbociclib,abemaciclib,and dalpiciclib as first-line treatments for Chinese HR+/HER2−metastatic breast cancer patients: a multicenter study (YOUNGBC-28)

Yifan Chen, Yizhao Xie, Die Sang [...]

Therapeutic Advances in Medical Oncology

Select article: Capivasertib/Fulvestrant in patients with HR+,HER2-low or HER2-negative locally advanced or metastatic breast cancer

Open access

Review article

First published 2025

Capivasertib/Fulvestrant in patients with HR+,HER2-low or HER2-negative locally advanced or metastatic breast cancer

Karam Aboud, Magda Meissner, Rob Jones

Therapeutic Advances in Medical Oncology

Select article: Cost-effectiveness of ribociclib plus letrozole versus palbociclib plus letrozole or letrozole as monotherapy in first-line treatment of postmenopausal women with HR+/HER2− locally advanced or metastatic breast cancer: a Brazilian private payer perspective

Open access

Research article

First published 2021

Cost-effectiveness of ribociclib plus letrozole versus palbociclib plus letrozole or letrozole as monotherapy in first-line treatment of postmenopausal women with HR+/HER2− locally advanced or metastatic breast cancer: a Brazilian private payer perspective

Anna Maria Buehler, Gabriela Castilho, Pierre-Alexandre Dionne [...]

Therapeutic Advances in Medical Oncology

Select article: Elacestrant plus alpelisib in an ESR1 and PIK3CA co-mutated and heavily pretreated metastatic breast cancer: the first case report for combination efficacy and safety

Open access

Case report

First published 2024

Elacestrant plus alpelisib in an ESR1 and PIK3CA co-mutated and heavily pretreated metastatic breast cancer: the first case report for combination efficacy and safety

Ünal Metin Tokat, Şevval Nur Bilgiç, Esranur Aydın [...]

Therapeutic Advances in Medical Oncology

1
2
3
•••
7
10 / page

Article type

Publication date

Subjects

Access